Using a computational technique that accounts for how genes interact, scientists revealed genes that may be related to autism spectrum disorder.
Alnylam Pharmaceuticals has announced positive results from its latest phase 3 clinical trials of patisiran, the company’s lead drug.
Could the technology we have developed to design viruses and vaccines one day be used to kill us? The answer boils down to who is in control.
Sophia Genetics has raised $30 million in Series D funding in a bid to accelerate its mission of democratising data-driven medicine worldwide.
Craig Venter’s start-up, Human Longevity hasn’t fulfilled its promises as it faces backlash from critics.
Scientists are working on new gene engineering method that could eventually allow us to grow our own organs for transplants.
Having worked more than a decade for Pfizer, and shared lab with 2013 Nobel Prize Winner Michael Levitt, Enoch Huang gives us an insight into his life.
Institute of Pathology Heidelberg Joins Thermo Fisher Scientific Center of Excellence Program to Drive Oncology Companion Diagnostic Development in Europe.
The NIH have announced three Health Provider Organisations that will help to enrol and manage participants in the Precision Medicine Initative’s All of Us program
The preliminary data from the largest GWAS into clinical depression highlights that current treatments are far from perfect.